MedTrace Logo

the Effect Site Equilibration Time of Propofol is Age Dependant

NCT01586013 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2012-04-26

No results posted yet for this study

Summary

This study obtains an effect site model for White (Modified Marsh) pharmacokinetic propofol model. The plasma effect-site rate constant (ke0) obtained is affected by age.

Conditions

  • Healthy

Interventions

DRUG

evaluation of propofol effect using BIS

propofol administered in target controlled infusion using the pharmacokinetic model of White

Sponsors & Collaborators

  • Universidad del Desarrollo

    lead OTHER

Principal Investigators

  • Pablo O Sepulveda, Dr · Clinica Alemana Universidad del Desarrollo

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01586013 on ClinicalTrials.gov